A Clinical Investigation Examining the Performance and Handling of New 2-piece Ostomy Products in 28 People With an Ileostomy.
Not Applicable
Completed
- Conditions
- Ileostomy - Stoma
- Registration Number
- NCT02064231
- Lead Sponsor
- Coloplast A/S
- Brief Summary
To assess the functionality and safety of the test products and also assess the products ability to collect stool without interfering with the stoma.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 28
Inclusion Criteria
- Had given written informed consent
- Was at least 18 years of age
- Was able to handle the appliances themselves or with help from a caregiver (e.g. spouse)
- Had an ileostomy with a diameter between 15-45 mm
- Have had an ileostomy for at least 3 months
- Currently used a 2-piece flat appliance
Exclusion Criteria
- Used irrigation during the investigation (flush stoma with water)
- Currently received or had within the past 2 months received radio- and/or chemotherapy.
- Currently received or had within the past month received local or systemic steroid treatment in the peristomal area.
- Was pregnant or breast feeding
- Participated in other interventional studies that could interfere with this one or had previously participated in this investigation.
- Had a baseplate wear time of more than three days
- Suffered from peristomal skin problems that precluded participation in the investigation (assessed by the investigation nurse)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method Degree of Leakage 14 days Degree of leakage is measured on a 24 point scale where 0 represents no leakage (best possible outcome) and 24 represents leakage on the whole plate (worst possible outcome).
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the functionality of 2-piece ostomy devices in ileostomy management?
How does the performance of Coloplast Test A compare to standard-of-care ileostomy products in terms of stool collection efficiency and stoma compatibility?
Are there specific biomarkers or patient characteristics that correlate with better outcomes using 2-piece ostomy systems in ileostomy patients?
What are the potential adverse events associated with 2-piece ostomy devices and how can they be managed in clinical practice?
How do Coloplast's 2-piece ostomy products compare to competitor devices in terms of innovation, patient adherence, and long-term stoma health outcomes?